The most influential Megatrends set to shape the world through 2030, identified by Euromonitor International, help businesses better anticipate market developments and lead change for their industries.
Learn moreEuromonitor addresses your unique questions and challenges across all B2B and B2C industries and geographies through custom, tailor-made research projects, designed to your specific goals.
Learn moreJun 2020
US$990Added to Cart
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
The growth in rx/reimbursement adult incontinence is, as with retail adult incontinence, stimulated by a growing and ageing population in Sweden. The risk of being affected by incontinence concerns increases considerably the older a person gets, and it is estimated by the Swedish Medical Products Agency that half of the costs for rx/reimbursement adult incontinence products are related to people that are 80 years or older.
In order for Swedish consumers to get access to the rx/reimbursement adult incontinence products provided by the government, they have to go through a certain process. People that experience incontinence problems will have to get in touch with a doctor, nurse or health professional in order to be examined and diagnosed.
Even though there is still some stigma attached to incontinence products, it is gradually disappearing. In a report from Västmanlands län, a county in Sweden, the number of orders of rx/reimbursement incontinence products in 2018 grew by 17.
Sales of rx/reimbursement adult incontinence are expected to grow by 3% at constant 2019 prices in 2020. This is the same forecast performance that appeared in our 2020 edition published in February 2020 (pre-COVID-19).
If COVID-19 results in a prolonged or very harsh economic downturn in Sweden, this could help rx/reimbursement adult incontinence, given the category’s products are available free through prescription. However, the short- and medium-term forecast performance currently looks unchanged for these products.
Files are delivered directly into your account within a few minutes of purchase.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.
Files are delivered directly into your account within a few minutes of purchase.
Discover the latest market trends and uncover sources of future market growth for the Rx/Reimbursement Adult incontinence industry in Sweden with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Rx/Reimbursement Adult incontinence industry in Sweden, our research will save you time and money while empowering you to make informed, profitable decisions.
The Rx/Reimbursement Adult incontinence in Sweden market research report includes:
Our market research reports answer questions such as:
This industry report originates from Passport, our
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.